Produkty 100239-45-0

CAS 100239-45-0 występuje w naszej ofercie pod nazwami: 3beta-hydroxytibolone, 3beta-Hydroxy Tibolone, >95% (HPLC), 3beta-Hydroxy Tibolone (1mg/ml in Acetonitrile). Oferty producentów: Chemat Brand, TRC. Dostępne opakowania: on request, 10mg, 5mg, 1x1ml.

3beta-hydroxytibolone
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
3beta-Hydroxy Tibolone, >95% (HPLC)
TRC
  • opakowanie: 10mg, 5mg
  • Warianty: 2
Zobacz produkt
3beta-Hydroxy Tibolone (1mg/ml in Acetonitrile)
TRC
  • opakowanie: 1x1ml
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,7R,8R,9S,13S,14S,17R)-17-ethynyl-7,13-dimethyl-2,3,4,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol (CAS 100239-45-0) to związek chemiczny o wzorze sumarycznym C21H30O2 i masie molowej 314.5 g/mol. Nazwa systematyczna IUPAC: (3S,7R,8R,9S,13S,14S,17R)-17-ethynyl-7,13-dimethyl-2,3,4,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol. InChIKey: YLEUWNOTNJZCBN-XAAPQAIWSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H30O2
Masa molowa314.5 g/mol
Nazwa IUPAC(3S,7R,8R,9S,13S,14S,17R)-17-ethynyl-7,13-dimethyl-2,3,4,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol
InChIKeyYLEUWNOTNJZCBN-XAAPQAIWSA-N
SMILESC[C@@H]1CC2=C(CC[C@@H](C2)O)[C@@H]3[C@@H]1[C@@H]4CC[C@]([C@]4(CC3)C)(C#C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 3beta-hydroxytibolone, 3b-Hydroxy Tibolone, 3?-Hydroxy Tibolone, 3beta-Hydroxy Tibolone (1mg/ml in Acetonitrile), Tibolone impurity 2, 3beta-Hydroxy Tibolone, YLEUWNOTNJZCBN-XAAPQAIWSA-N, 7alpha-Methyl-17alpha-19-norpregn-5(10)-en-20-yne-3beta,17-diol
Powiązane formy tego związku
(3R,7R,8R,9S,13S,14S,17R)-17-ethynyl-7,13-dimethyl-2,3,4,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol C21H30O2
Izomery (ten sam wzór sumaryczny)
1-[(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H30O2
methyl (1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate C21H30O2
(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol C21H30O2
[(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-4,5,6,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C21H30O2
(8R,9S,13S,14S,17S)-13-methyl-3-propoxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-ol C21H30O2
4-[(6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]benzene-1,2-diol C21H30O2
(8S,9R,10S,13S,14S,17S)-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C21H30O2
(6aR,10aS)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol C21H30O2
2-methyl-2-(4-methylpent-3-enyl)-7-pentylchromen-5-ol C21H30O2
(8S,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O2
[(3S,8S,9S,10R,14S)-10,17-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate C21H30O2